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ABSTRACT
Introduction. Post-operative pain con-
trol improves surgical outcome and many 
hospitals created multidisciplinary teams, 
called “Acute Pain Services” (APS). We col-
lected APS data on 10,760 adult patients 
over a five year period, including compli-
cations, side effects and patient satisfac-
tion.
Methods. Data on patients managed by 
APS in a high surgical-volume university 
hospital over a 5-year period were col-
lected and analyzed. Data included demo-
graphic characteristics, primary analgesic 
modality, adjuvant analgesic treatment, 
type of surgical procedure, Visual Ana-
logue Scale, and analgesia-related side-
effects and complications.
Results. Patient controlled analgesia with 
morphine was used in 4,992 surgical pa-
tients while epidural analgesia was used in 
3,687 surgical patients and 1,670 pregnant 
women for delivery analgesia. A total of 411 
patients received other forms of analgesia. 
No epidural haematoma was observed. A 
single case of respiratory depression oc-
curred in an elderly patient using the pa-
tient controlled analgesia system. Acetami-
nophen was the most frequently adjuvant 
drug prescribed. Postoperative nausea and 
vomiting was the most frequent analgesia-
related side effect. Visual Analogue Scale at 
rest and on movement was low on day one 
(0.84±1.15 and 2.05±1.67) and decreased 
thereafter with epidural analgesia associ-
ated with better pain control following hip 
and liver surgery, and with less postop-
erative nausea and vomiting (5.0%) when 
compared to morphine patient controlled 
analgesia (7.2%).
Conclusions. An APS, with daily postop-
erative visits, permits adequate post-oper-
ative pain control without serious adverse 
events. Epidural analgesia was associated 
with less postoperative nausea and vom-
iting and had at least similar pain control 
than morphine patient controlled analge-
sia.
Key words: acute pain service, epidural an-
algesia, patient controlled analgesia, anes-
thesia, surgery
INTRODUCTION
The importance of adequate postopera-
tive pain control is widely accepted and 
its beneficial effects supported by several 
randomized studies and meta-analyses. 
(1-4) Pain has to be considered as other 
vital parameters (e.g. blood pressure, heart 
rate, breathing and respiratory rate, and 
diuresis) and has to be monitored at well-
defined time intervals and quickly treated 
if necessary. The need to create a “hospital 
without pain” is connected to multiple rea-
sons: first of all, pain is probably one of the 
most disturbing experiences and its treat-
ment is a moral and ethical imperative; 
furthermore, a painless patient is able to 
breathe easier, cough efficiently and move 
sooner; as a direct consequence he/she is 
less subject to cardiovascular complica-
tions, pulmonary infections and thrombo-
embolic events, and definitively presents a 
better postoperative outcome. (5-8)
Patient-controlled analgesia (PCA) and 
continuous epidural analgesia are associat-
ed with a reduction in postoperative mor-
bidity in defined categories of patients and 
surgeries. (8) However, these specialized 
techniques can be associated with serious 
neurologic, cardiovascular and respira-
tory complications if used in general wards 
without particular precautions. (5, 9)
Acute Pain Services (APS) have been in-
stituted in many hospitals to achieve effec-
tiveness and safety of postoperative pain 
management. A winning strategy is to cre-
ate a multidisciplinary team involving sur-
geons, nurses and anesthetists, where the 
latter assume a leading role thanks to their 
specific skills. (7, 8, 10) The APS team usu-
ally defines protocols to prevent pain in dif-
ferent types of surgery, taking into account 
the characteristics of specific categories of 
patients (e.g. the elderly). Moreover the 
APS should establish organizing models 
with regular assessment of pain intensity, 
therapy efficacy, and complications defin-
ing how to prevent and treat them as soon 
as possible. In order to ensure appropriate 
management of acute postoperative pain, 
the APS has an important role in train-
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ing patients and the medical and nursing 
staff involved in perioperative care, and in 
performing audits and clinical research on 
the efficacy of existing and new methods of 
treatment. (8, 10)
The aim of our study was to describe the 
5-year activities of the APS of a large sur-
gical center focusing on major and minor 
complications of epidural analgesia and 
intravenous opiates together with a com-
parison of postoperative pain management 
between these two strategies.
MATERIALS AND METHODS
With approval of the local Ethical Com-
mittee (San Raffaele Ethical Committee, 
protocol OSR 33, June 23rd 2014) and 
patients’ written informed consent for the 
scientific management of their data we col-
lected the 5 year activity data of the APS 
of San Raffaele Scientific Institute based 
in Milan, Italy. This is a 1,357 bed refer-
ral center (1), with approximately 30,000 
major procedures performed each year 
and with 90 anesthesiologists managing 
anaesthesia, intensive care, emergency de-
partment and APS. An anesthesia fellow 
is available 24 hour a day and seven days 
per week, dedicated to the management of 
postoperative pain and to the prevention 
and treatment of possible complications. 
A senior anesthetist can be contacted at 
every moment for any problem.
The choice of a specific pain management 
approach starts with a thorough preopera-
tive evaluation that takes into account the 
characteristics of the single patient (e.g. 
previous surgery, pre-existing analgesic 
therapy, psychological attitude, drug al-
lergies/intolerances, etc.) and the specific 
type of surgery. The anesthetist plays a 
leading role in a complex team, includ-
ing surgeons and nurses, and coordinates 
all the personnel to promote a continuous 
path of education and improvement of the 
adopted protocols.
Epidural catheters are placed immediately 
before surgery while the patient is still 
awake.
All postoperative patients receive either 
acetaminophen 1 g or a non-steroidal anti-
inflammatory drug (NSAID) at fixed inter-
vals with the possibility of receiving other 
agents as rescue therapy (table 1). We col-
lected data on patients undergoing major 
abdominal surgery (e.g. hepatic and gastric 
surgery, colo-rectal resection, laparoscopic 
and laparotomic esophagectomy), gyneco-
logical (e.g. myomectomy, hysterectomy), 
orthopedic (e.g. hip and knee replace-
ment), neurosurgical and ear-throat-nose 
procedures. Due to different databases and 
organizational issues, we did not collect 
any data on cardiac surgery patients, only 
PCA data in vascular, thoracic and uro-
logic operations, and only major complica-
tions and post-dural puncture headaches 
(PDPH) after delivery with epidural an-
algesia. Therefore, patients receiving epi-
dural analgesia for delivery were excluded 
from the analysis.
Patients managed by APS included patients 
treated with epidural analgesia (with the 
exceptions described above), through the 
intravenous administration of morphine 
by on demand PCA systems or with peri-
neural catheters (in selected orthopedic 
patients) with specific protocols detailed 
in table 1. Furthermore, APS also managed 
patients with inadequate control of pain 
even seven days after surgery, in which it 
was necessary to define a therapy regime 
to be continued at home.
All patients are visited at least once a day, 
for up to seven days after surgery or refer-
ral to APS (more than once in the case of 
recent APS modifications to pain therapy 
or if requested by ward staff or physicians) 
if still in the hospital.
The APS use the Visual Analogue Scale 
(VAS) at rest (VASr) and during move-
ment (VASm) to standardize pain assess-
ment at each visit and assess the presence 
of side effects and complications.
The APS is also responsible for the re-
moval of epidural catheters and neuro-
logical surveillance in the first 6-8 hours 
after removal. Removal of the epidural 
catheter follows the same guidelines as for 
epidural catheter insertion: platelet count 
> 100×109/L; International Normalized 
Ratio < 1.3; no dual antiplatelet therapy; 
no antiplatelet drugs such as ticlopidine 
and clopidogrel; no anticoagulants; low 
molecular weight heparin suspended for at 
least 10-12 hours. (11)
All the data collected are stored in an elec-
tronic database in order to allow quick and 
efficient communication between different 
anesthetists involved in pain care on differ-
ent days and to ensure continuity of care.
We recorded age, sex, type of surgery, ASA 
score, prescribed therapy, analgesic tech-
nique used, daily VASr and VASm, side 
effects and adverse events: respiratory de-
pression, epidural hematoma, postopera-
tive nausea and vomiting (PONV), pares-
thesia, itching, hypotension and confusion.
We compared effectiveness of pain control 
in patients of different ages and in patients 
with an American Society of Anesthesi-
ologists (ASA) physical status class (ASA 
score) of 1-2 versus > 2.
STATISTICAL ANALYSIS
Data were stored electronically and ana-
lyzed with SAS (release 9.2 by SAS In-
stitute Inc. Cary, NC, USA) and STATA 
(StataCorp. 2013. Stata Statistical Software: 
Release 13. College Station, TX: StataCorp 
LP). Categorical variables are reported as 
frequencies (percent), whereas continuous 
variables are expressed as mean ± stand-
ard deviation or as median (interquartile 
range). As for categorical variables, Chi-
squared test was used to calculate p-values 
when two groups were compared, whereas 
one-way ANOVA was used in comparing 
more than two groups. A p-value <0.05 
was considered statistically significant.
RESULTS
Over a five year period the APS followed 
10,760 adult patients for a total of 24,240 
visits. The 1,670 women receiving epidural 
analgesia for delivery had no epidural he-
matoma and 21 PDPH, and were excluded 
from analysis. The remaining 9,090 pa-
tients were 60±15 years old, equally di-
vided between male and female, and 24.1% 
were ASA physical status class 3 (table 2).
The APS mainly visited patients admitted 
to the Division of General Surgery (5,703; 
62.7%).
The overall number of patients receiving 
epidural analgesia alone was 3,687 (40.6%), 
while 4,992 patients (54.9%) received PCA 
alone. Combined epidural analgesia plus 
PCA was used in 58 (0.6%) patients.
In addition, APS followed orthopedic 
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patients with perineural catheters (298 
patients, 3.3%) and patients whose post-
operative pain treatment was very difficult 
even if not requiring a PCA or an epidural 
infusion (55 patients, 0.6%) (figure 1, these 
last ones are classified in the figure as “oth-
er”, including patients undergoing surgery 
associated with mild or moderate pain, but 
who presented with difficult pain control 
according to the standard protocol, re-
quiring specific solutions, e.g. continuous 
infusion of tramadol or strong oral opi-
ates such as oxycodone). Acetaminophen 
(4,971 patients, 54.7%), at fixed intervals, 
was the most frequently prescribed adju-
vant drug.
Pain control was excellent on postopera-
tive day 1 (VASr and VASm were 0.84±1.15 
and 2.05±1.67 respectively) and decreased 
day after day. VASr on the 7th post-oper-
ative day was 0.581.01 (p<0.05, t=3.595, 
df=8482) and VASm was 1.561.65 (p<0.05, 
t=4.6710, df= 8471) (Supplementary table 
1 in Supplementary appendix). The num-
ber of patients with VAS 0 was significantly 
(p<0.05) higher in the group of patients 
receiving epidural analgesia for orthope-
dic surgery on day 3 (79.8% vs 62.1% for 
VASr) and for hepatic surgery on day 1, 
day 2 and day 5 when compared to PCA.
Figure 1. Main analgesic techniques used 
year by year.
PCA, Patient Controlled Analgesia; PNC, 
Perineural Catheter.
Figure 2. Number of patients experiencing 
analgesia-related side effects in different 
postoperative days.
No epidural hematoma, epidural abscess or 
meningitis occurred in the patients receiv-
ing an epidural catheter and no permanent 
alteration in sensitive or motor functions 
was observed. One episode of respira-
tory depression occurred among patients 
managed with morphine PCA. This was 
due to a pump programming error in a 92 
year old ASA 4 patient after an explorative 
laparotomy for intestinal occlusion. It was 
promptly treated with naloxone infusion 
and the patient did not require intensive 
care unit admission. No cardiac arrest was 
associated with analgesic protocols in the 
study period.
The number of patients experiencing an-
algesia-related side effects was 12.3% on 
the first postoperative day and rapidly de-
creased thereafter (figure 2).
The most frequently treated side effects 
on the first postoperative day were PONV 
(6.0%), paresthesia (3.7%), itching (1.4%), 
hypotension (0.5%) and confusion (0.2%). 
Epidural analgesia was associated with a 
significant (2=17.23, p<0.05) reduced inci-
dence of PONV in the first postoperative 
day as compared with morphine PCA ad-
ministration (5.0% vs 7.2%).
Table 1. Protocols adopted according to the intensity of pain.
Grade of pain Pain management strategy adopted
Mild pain (e.g. hysteroscopy) Acetaminophen 1 g x 3/4 iv or NSAID
NSAID or acetaminophen 1 g as rescue.
Moderate pain (e.g. Cholecystectomy) Acetaminophen 1 g x 3/4 iv or NSAID.
Weak opiates (e.g. tramadol).
NSAID or acetaminophen 1 g as rescue.
Severe pain (e.g. gastrectomy, hepatic resection, etc.)
Epidural catheter analgesia
Acetaminophen 1 g x 3/4 iv or NSAID.
Epidural catheter or PCA of morphine.
NSAID or acetaminophen 1g or weak opiates (e.g. tramadol) as rescue.
Position according to the kind of surgery.
Intraoperative bolus of sufentanyl 10 mcg at the beginning of surgery 
in all patients and of local anesthetic at anesthesiologist discretion.
Intra- and post-operative infusion of ropivacaine 0.2% 99 ml + sufen-
tanyl 50 mcg/1 ml at 4-6 ml/h
PCA with morphine Injection dose 1 mg iv
Lock out time of 10 minutes
Maximum mg for hours: 4
No continuous infusion
Perineural catheter Infusion of ropivacaine 0.2% 8-10 ml/h
Intraoperative bolus of local at anesthesiologist discretion
Severe pain was treated with postoperative epidural analgesia, PCA with morphine or perineural analgesia.
I.v, intravenous; NSAID, non-steroidal anti-inflammatory drug; PCA, patient-controlled analgesia.
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Table 2. Characteristics of 9,090 patients visited by the APS during a 5 year period.
Variable Data
Male, n (%) 4525 (49.8%)





















































Data are expressed as number (%) or mean (standard deviations).
APS, acute pain service; ASA, American Society of Anesthesiologists; NSAIDs, non-steroidal anti-inflammatory drugs; PCA, patient-
controlled analgesia; PNC, perineural catheter.
Table 3. The largest studies published on acute pain services.
Authors N Journal Year Study
Present study 10,760 2016 Epidural analgesia was associated with a reduction in 
postoperative nausea and vomiting when compared to 
morphine PCA. A single episode of respiratory depression 
was reported. No cases of spinal hematoma or bacterial 
meningitis were reported.
Paul JE et al. (9) 35,384 Anesthesiology 2014 Evaluation of adverse events in three hospitals before and 
after a formal root cause analysis process. 165 episodes 
of respiratory depression, 4 epidural abscesses, 2 spinal 
hematoma and 2 deaths were reported.
Pöpping DM et al. (10) 18,925 British Journal of Anaesthesiology 2008 Epidural analgesia and peripheral nerve block provided 
superior pain relief than endovenous PCA. 3 cases of 
epidural hematoma, 2 of epidural abscess, 1 of bacterial 
meningitis and 1 of respiratory depression were reported.
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Schug SA et al. (13) 3,016 Pain 1993 Potentially severe complications without sequelae oc-
curred in 16 patients (0.53%). No trauma to nervous 
structure, no infections, and no local anesthetic toxicity 
occurred with continuous regional analgesia (epidural, 
interpleural and peripheral).
Flisberg P et al. (3) 2,696 Acta Anesthesiologica Scandi-
navica
2003 Patients with epidural analgesia experienced less pain 
than those with endovenous PCA. Twenty episodes of 
respiratory depression and one epidural haematoma were 
reported.
Syngelin FJ et al. (14) 1,338 Journal of Clinical Anesthesia 1999 Patients undergoing hip surgery. Epidural analgesia, 
endovenous PCA and “3-in-1” continuous block provided 
comparable pain relief. No serious adverse events were 
registered.
PCA, patient-controlled analgesia.
The Visual Analogue Scale at rest and 
during movement was significantly lower 
in elderly patients compared with young 
patients on treatment day 1 and this dif-
ference persisted until day 5. In addition, 
older patients reported significantly lower 
incidence of PONV and paresthesia (Sup-
plementary tables 2, 3 in Supplementary 
appendix).
We found that VASm was higher in pa-
tients with an ASA score >2 compared 
with patients with an ASA 1-2 on treat-
ment days 1 to 4, while no difference was 
reported for VASr. However, patients with 
an ASA score 1-2 had a higher incidence 
of PONV, paresthesias and itching (Sup-
plementary tables 4-7 in Supplementary 
appendix).
When analyzing the subgroups of patients 
receiving epidural analgesia or PCA alone, 
data confirmed that VASr and VASm were 
higher in youngest patients in the first 
treatment days. Incidence of PONV was 
significantly lower in older patients, both 
in the subgroups receiving epidural analge-
sia and PCA, while a significant difference 
in incidence of paresthesia was found only 
in the epidural subgroup (Supplementary 
tables 8-19 in Supplementary appendix).
DISCUSSION
We present one of the largest case series of 
APS ever reported, confirming that the use 
of epidural analgesia and intravenous PCA 
with morphine in surgical wards is effec-
tive and safe with no major complications 
and a reasonable number of minor side 
effects. This was the second largest single 
center experience ever reported in the 
medical literature describing both epidural 
and intravenous PCA analgesia technique.
Although the risk of related adverse effects 
initially limited the use these analgesic 
techniques outside “safe settings” such as 
intensive care units, studies and surveys 
have shown that continuous epidural and 
patient-controlled intravenous analgesia 
greatly improve postoperative pain relief 
with a low rate of complications. (5,9)
We also found a very low incidence of side 
effects, which were quickly detected and 
resolved without affecting the postopera-
tive course. Unlike other studies, we did 
not observe any case of spinal hematoma. 
A possible explanation is that, in our hos-
pital, epidural catheter placement and 
removal follows very strict criteria. Our 
data also showed that epidural analgesia 
provides slightly superior pain relief with 
less PONV when compared to intravenous 
opiates PCA. These results are consistent 
with the literature, and the lower incidence 
of PONV in our setting can be explained 
by the use of small doses of neuraxial opi-
oids. (5,9)
An extensive literature review confirmed 
that our case series is one of the largest 
(5, 9, 12-14) ever reported on APS and 
the second largest single center case series 
comparing epidural and PCA analgesia. In 
table 3, we summarized the largest pub-
lished studies on this topic and report the 
most commonly reported complications.
The reduced incidence of severe side ef-
fects observed in our study is in line with 
other excellent perioperative results (15) 
reported by our group in other settings and 
cannot be easily explained.
To ensure a “pain and risk free” postopera-
tive course, close supervision of patients 
treated with these specialized pain relief 
methods by an APS is mandatory. The pro-
tocols and the organization we described 
in the methods allowed us to obtain such 
excellent results.
As previously reported in the literature, 
we found in our study that older patients 
had better pain control and a reduced in-
cidence of side effects when compared to 
younger patients. (16) This might be due 
to the fact that elderly people frequently 
suffer from chronic pain, and therefore 
consider pain as part of the ageing process. 
(17) Presence of cognitive impairment has 
also been associated with reduced analge-
sic prescription in the elderly. (18)
Another interesting finding of our study is 
that both the incidence of pain and anal-
gesia-related side effects is different in pa-
tients with a different ASA physical status 
class. Patients with higher ASA class had 
less satisfactory pain control compared 
to those of ASA class 1-2. This might be 
explained by the fact that patients with 
higher ASA class > 2 have chronic sys-
temic diseases associated with pain, or that 
they lead physicians to reduce analgesics 
doses to avoid possible complications (e.g. 
NSAIDs in patients with chronic kidney 
disease, or opioids in patients with chronic 
pulmonary diseases). This might also ex-
plain the lower incidence of side effects 
reported by these patients.
STUDY LIMITATIONS
Our study has some limitations. First of all, 
it is an observational study. Furthermore, 
       SIGNA VITAE    |    83
we excluded from the data collection 
some settings (e.g. vascular surgery) that 
take great advantage of epidural analgesia 
but are prone to develop epidural haema-
toma because of preoperative antiplatelet 
therapy and intraoperative systemic hep-
arinization. Another limitation is the lack 
of information regarding the postoperative 
course, in particular the length of hospital 
stay, the recovery of intestinal function 
and the rate of respiratory complications 
even if our hospital is known to perform 
well when comparing these outcomes with 
other centers worldwide. (15) Attention is 
now being directed toward the introduc-
tion of new approaches to perioperative 
care aimed at improving outcome and 
shortening recovery after surgery. Effective 
treatment of postoperative pain certainly 
contributes to achieving this goal, and, in 
addition to providing a direct benefit to 
the patient, it could also be profitable for 
the health care system. Cost-effectiveness 
analysis, in fact, must consider both direct 
costs associated with analgesic drugs, de-
vices, nursing and physician time, length 
of stay in the intensive care unit or surgi-
cal ward, and postoperative morbidity, and 
the indirect costs of improved analgesia 
and patient satisfaction. In our study, these 
aspects have not been taken into account 
but are important to ensure better use of 
hospital resources and improve the quality 
of care. Furthermore, adjusted p-value for 
multiple comparison tests was not taken 
into account.
The strengths of this study are that it has 
a very low incidence of severe analgesia-
related complications and that it includes 
a very large number of patients.
CONCLUSIONS
Our large study demonstrates that an APS, 
with daily postoperative visits, is effective 
in providing adequate post-operative pain 
control without serious adverse events. 
Compared with PCA with morphine, epi-
dural analgesia was associated with a lower 
incidence of postoperative nausea and 
vomiting with a similar effectiveness in 
pain control.
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SUPPLEMENTARY APPENDIX




Mean ± SD 0.84 ± 1.147 2.05 ± 1.674
> Day 2
Mean ± SD 0.65 ± 0.983 1.93 ± 1.514
> Day 3
Mean ± SD 0.48 ± 0.865 1.67 ± 1.526
> Day 4
Mean ± SD 0.47 ± 0.915 1.62 ± 1.564
> Day 5
Mean ± SD 0.55 ± 1.019 1.67 ± 1.653
> Day 6
Mean ± SD 0.65 ± 1.220 1.73 ± 1.725
> Day 7
Mean ± SD 0.58 ± 1.014 1.56 ± 1.654
Table 2. Visual Analogue Scale at rest (VASr) per age.
SD, standard deviation.
VASr <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 0.99 ± 1.324 0.85 ± 1.125 0.78 ± 1.079 0.78 ± 1.119 <0.001*
> Day 2
Mean ± SD 0.78 ± 1.146 0.67 ± 0.990 0.59 ± 0.906 0.56 ± 0.858 <0.001*
> Day 3
Mean ± SD 0.57 ± 0.981 0.48 ± 0.869 0.47 ± 0.831 0.34 ± 0.671 <0.001*
> Day 4
Mean ± SD 0.55 ± 0.965 0.51 ± 0.965 0.42 ± 0.842 0.39 ± 0.938 0.037 *
> Day 5
Mean ± SD 0.72 ± 1.111 0.57 ± 1.065 0.47 ± 0.935 0.55 ± 1.062 0.042*
> Day 6
Mean ± SD 0.79 ± 1.123 0.66 ± 1.119 0.62 ± 1.384 0.37 ± 1.033 0.39
> Day 7
Mean ± SD 0.75 ± 1.055 0.66 ± 1.005 0.46 ± 1.041 – 0.078
 
Table 3. Visual Analogue Scale during movement (VASm) per age.
SD, standard deviation.
VASm <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 2.22 ± 1.793 2.07 ± 1.633 1.94 ± 1.560 1.98 ± 1.602 <0.001*
> Day 2
Mean ± SD 2.04 ± 1.620 1.96 ± 1.532 1.86 ± 1.457 1.84 ± 1.454 0.0045*
> Day 3
Mean ± SD 1.90 ± 1.646 1.68 ± 1.530 1.60 ± 1.496 1.45 ± 1.369 <0.001*
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> Day 4
Mean ± SD 1.89 ± 1.513 1.69 ± 1.594 1.54 ± 1.546 1.37 ± 1.541 <0.001*
> Day 5
Mean ± SD 1.97 ± 1.725 1.65 ± 1.662 1.56 ± 1.610 1.65 ± 1.692 0.044*
> Day 6
Mean ± SD 2.04 ± 1.716 1.73 ± 1.638 1.64 ± 1.847 1.47 ± 1.525 0.22
> Day 7
Mean ± SD 1.78 ± 1.706 1.61 ± 1.609 1.30 ± 1.581 1.73 ± 1.902 0.36
Table 4. Visual Analogue Scale at rest (VASr) per ASA score.
ASA, American Society of Anesthesiologists score; SD, standard deviation.
VASr ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 0.83 ± 1.129 0.85 ± 1.170 0.44
> Day 2
Mean ± SD 0.64 ± 0.971 0.69 ± 1.016 0.059
> Day 3
Mean ± SD 0.46 ± 0.845 0.52 ± 0.908 0.056
> Day 4
Mean ± SD 0.45 ± 0.907 0.52 ± 0.930 0.076
> Day 5
Mean ± SD 0.53 ± 1.020 0.56 ± 0.991 0.66
> Day 6
Mean ± SD 0.65 ± 1.264 0.64 ± 1.100 0.99
> Day 7
Mean ± SD 0.52 ± 0.897 0.65 ± 1.202 0.34
Table 5. Visual Analogue Scale during movement (VASm) per ASA score.
ASA, American Society of Anesthesiologists score; SD, standard deviation.
VASm ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 2.01 ± 1.638 2.14 ± 1.654 0.003*
> Day 2
Mean ± SD 1.88 ± 1.505 2.08 ± 1.535 <0.001*
> Day 3
Mean ± SD 1.60 ± 1.511 1.86 ± 1.549 <0.001*
> Day 4
Mean ± SD 1.59 ± 1.571 1.74 ± 1.531 0.032*
> Day 5
Mean ± SD 1.65 ± 1.698 1.71 ± 1.518 0.57
> Day 6
Mean ± SD 1.74 ± 1.807 1.70 ± 1.729 0.80
> Day 7
Mean ± SD 1.48 ± 1.613 1.61 ± 1.662 0.58
 
86   |  SIGNA VITAE
Table 6. Distribution of treated side effects per age.
PONV, post-operative nausea and vomiting.
Age
Treated side effects <45 45-64 65-79 >79 p-value
PONV 138 (9.2) 208 (6.1) 176 (5.0) 24 (3.7) <0.001*
paresthesia 87 (5.8) 141 (4.1) 95 (2.7) 15 (2.3) <0.001*
itching 21 (1.4) 46 (1.4) 51 (1.4) 5 (0.8) 0.61
confusion 2 (0.1) 8 (0.2) 7 (0.2) 3 (0.5) 0.49
hypotension 2 (0.1) 17 (0.5) 18 (0.5) 6 (0.9) 0.08
Table 7. Distribution of Treated side effects per ASA score.
ASA, American Society of Anesthesiologists; PONV, post-operative nausea and vomiting.
ASA
Treated side effects 1-2 >2 p-value
PONV 464 (6.7) 82 (3.8) <0.001*
paresthesia 313 (4.5) 25 (1.1) <0.001*
itching 106 (1.5) 17 (0.8) 0.007*
confusion 13 (0.2) 7 (0.3) 0.25
hypotension 35 (0.5) 8 (0.4) 0.40
 
Table 8. Visual Analogic Scale at rest (VASr) per age – Subanalysis for Epidural group.
SD, standard deviation.
VASr <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 0.98 ± 1.405 0.77 ± 1.050 0.74 ± 1.109 0.74 ± 1.044 0.0017*
> Day 2
Mean ± SD 0.78 ± 1.189 0.62 ± 0.953 0.56 ± 0.903 0.53 ± 0.842 <0.001*
> Day 3
Mean ± SD 0.55 ± 0.988 0.50 ± 0.902 0.46 ± 0.839 0.32 ± 0.638 0.026*
> Day 4
Mean ± SD 0.49 ± 0.896 0.52 ± 0.980 0.43 ± 0.859 0.33 ± 0.800 0.12
> Day 5
Mean ± SD 0.61 ± 1.032 0.53 ± 1.097 0.49 ± 1.001 0.53 ± 1.026 0.86
> Day 6
Mean ± SD 0.65 ± 1.075 0.64 ± 1.175 0.63 ± 1.495 0.12 ± 0.440 0.30
> Day 7
Mean ± SD 0.56 ± 0.922 0.60 ± 0.935 0.38 ± 0.991 – 0.25
Table 9. Visual Analogue Scale during movement (VASm) per age – Subanalysis for Epidural group. SD, standard deviation.
VASm <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 2.15 ± 1.895 1.88 ± 1.567 1.77 ± 1.593 1.90 ± 1.564 <0.001*
> Day 2
Mean ± SD 1.93 ± 1.661 1.80 ± 1.488 1.73 ± 1.446 1.77 ± 1.484 0.18
> Day 3
Mean ± SD 1.68 ± 1.653 1.56 ± 1.527 1.50 ± 1.451 1.43 ± 1.332 0.22
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> Day 4
Mean ± SD 1.84 ± 1.544 1.54 ± 1.622 1.44 ± 1.563 1.40 ± 1.514 0.041*
> Day 5
Mean ± SD 1.81 ± 1.620 1.55 ± 1.641 1.54 ± 1.701 1.68 ± 1.666 0.60
> Day 6
Mean ± SD 2.03 ± 1.672 1.67 ± 1.667 1.69 ± 1.965 1.28 ± 1.308 0.44
> Day 7
Mean ± SD 1.56 ± 1.723 1.34 ± 1.593 1.30 ± 1.520 2.00 ± 2.000 0.63
Table 10. Visual Analogue Scale at rest (VASr) per ASA score – Subanalysis for Epidural group.
ASA, American Society of Anesthesiologists score; SD, standard deviation.
VASr ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 0.78 ± 1.107 0.78 ± 1.172 0.99
> Day 2
Mean ± SD 0.60 ± 0.938 0.62 ± 1.047 0.65
> Day 3
Mean ± SD 0.47 ± 0.861 0.51 ± 0.888 0.43
> Day 4
Mean ± SD 0.45 ± 0.892 0.52 ± 0.996 0.23
> Day 5
Mean ± SD 0.52 ± 1.042 0.53 ± 1.031 0.85
> Day 6
Mean ± SD 0.62 ± 1.341 0.51 ± 1.073 0.50
> Day 7
Mean ± SD 0.41 ± 0.793 0.63 ± 1.234 0.21
Table 11. Visual Analogic Scale during movement (VASm) per ASA score – Subanalysis for Epidural group.
ASA, American Society of Anesthesiologists score; SD, standard deviation.
VASm ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 1.86 ± 1.617 1.91 ± 1.626 0.56
> Day 2
Mean ± SD 1.76 ± 1.464 1.91 ± 1.630 0.054
> Day 3
Mean ± SD 1.50 ± 1.486 1.72 ± 1.502 0.006*
> Day 4
Mean ± SD 1.48 ± 1.570 1.70 ± 1.641 0.039*
> Day 5
Mean ± SD 1.58 ± 1.691 1.61 ± 1.537 0.81
> Day 6
Mean ± SD 1.71 ± 1.850 1.62 ± 1.538 0.70
> Day 7
Mean ± SD 1.33 ± 1.563 1.63 ± 1.705 0.32
 
88   |  SIGNA VITAE
Table 12. Distribution of Treated side effects per age – Subanalysis for Epidural group.
PONV, post-operative nausea and vomiting.
Age
Treated side effects <45 45-64 65-79 >79 p-value
PONV 35 (7.8) 74 (5.3) 65 (4.2) 10 (3.3) 0.01*
paresthesia 80 (18) 130 (9.3) 87 (5.7) 14 (4.6) <0.001*
itching 12 (2.7) 37 (2.7) 44 (2.9) 3 (1.0) 0.32
confusion 0 (0.0) 1 (0.1) 2 (0.1) 1 (0.3) 0.55
hypotension 1 (0.2) 15 (1.1) 17 (1.1) 5 (1.7) 0.25
Table 13. Distribution of Treated side effects per ASA score – Subanalysis for Epidural group.
ASA, American Society of Anesthesiologists score; PONV, post-operative nausea and vomiting.
ASA
Treated side effects 1-2 >2 p-value
PONV 170 (5.5) 14 (2.3) 0.001*
paresthesia 286 (9.3) 25 (4.2) <0.001*
itching 86 (2.8) 10 (1.7) 0.12
confusion 3 (0.1) 1 (0.2) 0.51
hypotension 31 (1.0) 7 (1.2) 0.72
Table 14. Visual Analogue Scale at rest (VASr) per age – Subanalysis for PCA group.
PCA, patient control analgesia; SD, standard deviation.
VASr <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 1.00 ± 1.282 0.91 ± 1.165 0.79 ± 1.032 0.81 ± 1.193 <0.001*
> Day 2
Mean ± SD 0.79 ± 1.115 0.72 ± 1.011 0.62 ± 0.913 0.58 ± 0.880 0.0017*
> Day 3
Mean ± SD 0.58 ± 0.979 0.46 ± 0.815 0.48 ± 0.819 0.36 ± 0.710 0.035*
> Day 4
Mean ± SD 0.60 ± 1.015 0.48 ± 0.931 0.42 ± 0.820 0.49 ± 1.197 0.20
> Day 5
Mean ± SD 0.86 ± 1.211 0.60 ± 0.992 0.39 ± 0.756 0.69 ± 1.250 0.0037*
> Day 6
Mean ± SD 0.89 ± 1.153 0.71 ± 1.054 0.53 ± 0.981 2.00 ± 2.160 0.049*
> Day 7
Mean ± SD 0.85 ± 1.099 0.73 ± 1.071 0.63 ± 1.212 – 0.83
Table 15. Visual Analogue Scale during movement (VASm) per age – Subanalysis for PCA group.
PCA, patient control analgesia; SD, standard deviation.
VASm <45 45-64 65-79 >79 p-value
> Day 1
Mean ± SD 2.27 ± 1.734 2.22 ± 1.650 2.07 ± 1.567 2.07 ± 1.690 0.013*
> Day 2
Mean ± SD 2.14 ± 1.584 2.13 ± 1.550 1.99 ± 1.459 1.91 ± 1.430 0.036*
> Day 3
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Mean ± SD 2.04 ± 1.619 1.82 ± 1.512 1.73 ± 1.522 1.47 ± 1.432 <0.001*
> Day 4
Mean ± SD 1.93 ± 1.472 1.88 ± 1.525 1.69 ± 1.511 1.33 ± 1.651 0.023*
> Day 5
Mean ± SD 2.14 ± 1.833 1.82 ± 1.693 1.59 ± 1.402 1.50 ± 1.897 0.072
> Day 6
Mean ± SD 2.04 ± 1.758 1.79 ± 1.519 1.43 ± 1.443 2.75 ± 2.500 0.17
> Day 7
Mean ± SD 1.96 ± 1.675 1.97 ± 1.518 1.22 ± 1.865 – 0.26
Table 16. Visual Analogue Scale at rest (VASr) per ASA score – Subanalysis for PCA group. ASA, American Society of Anesthesiologists 
score; PCA, patient control analgesia; SD, standard deviation.
VASr ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 0.87 ± 1.127 0.88 ± 1.168 0.78
> Day 2
Mean ± SD 0.67 ± 1.000 0.72 ± 1.002 0.20
> Day 3
Mean ± SD 0.46 ± 0.822 0.52 ± 0.912 0.087
> Day 4
Mean ± SD 0.45 ± 0.939 0.51 ± 0.869 0.29
> Day 5
Mean ± SD 0.55 ± 0.975 0.59 ± 0.956 0.70
> Day 6
Mean ± SD 0.70 ± 1.079 0.80 ± 1.132 0.56
> Day 7
Mean ± SD 0.71 ± 0.997 0.65 ± 1.199 0.79
Table 17. Visual Analogue Scale during movement (VASm) per ASA score – Subanalysis for PCA group.
ASA, American Society of Anesthesiologists score; PCA, patient control analgesia; SD, standard deviation.
VASm ASA 1-2 ASA >2 p-value
> Day 1
Mean ± SD 2.13 ± 1.622 2.24 ± 1.657 0.052
> Day 2
Mean ± SD 2.02 ± 1.534 2.16 ± 1.485 0.013*
> Day 3
Mean ± SD 1.72 ± 1.523 1.94 ± 1.567 0.002*
> Day 4
Mean ± SD 1.77 ± 1.561 1.76 ± 1.437 0.91
> Day 5
Mean ± SD 1.78 ± 1.726 1.82 ± 1.505 0.80
> Day 6
Mean ± SD 1.75 ± 1.663 1.79 ± 1.520 0.84
> Day 7
Mean ± SD 1.77 ± 1.628 1.60 ± 1.694 0.66
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Table 18. Distribution of Treated side effects per age – Subanalysis for PCA group.
PCA, patient control analgesia; PONV, post-operative nausea and vomiting.
Age
Treated side effects <45 45-64 65-79 >79 p-value
PONV, n (%) 102 (11) 132 (7.1) 110 (5.9) 14 (4.5) <0.001*
paresthesia, n (%) 2 (0.2) 3 (0.2) 2 (0.1) 0 (0.0) 0.81
itching, n (%) 10 (1.1) 9 (0.5) 6 (0.3) 2 (0.6) 0.089
confusion, n (%) 2 (0.2) 7 (0.4) 5 (0.3) 2 (0.6) 0.64
hypotension, n (%) 1 (0.1) 1 (0.1) 1 (0.1) 1 (0.3) 0.45
 
Table 19. Distribution of Treated side effects per ASA score – Subanalysis for PCA group. ASA, American Society of Anesthesiologists score; 
PCA, patient control analgesia; PONV, post-operative nausea and vomiting.
ASA
Treated side effects 1-2 >2 p-value
PONV 290 (8.4) 68 (4.4) <0.001*
paresthesia 7 (0.2) 0 (0.0) 0.11
itching 20 (0.6) 7 (0.5) 0.57
confusion 10 (0.3) 6 (0.4) 0.57
hypotension 3 (0.1) 1 (0.1) 0.99
